Williams K J, Boyle J M, Birch J M, Norton J D, Scott D
CRC Department of Cancer Genetics, Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Manchester, UK.
Oncogene. 1997 Jan 23;14(3):277-82. doi: 10.1038/sj.onc.1200838.
Cancer predisposition in approximately 60% of Li-Fraumeni Syndrome (LFS) families is associated with germline mutation of the TP53 gene. The p53 protein has been shown to mediate G1 arrest following DNA damage. We have investigated gamma-irradiation-induced transient and permanent G1 arrest in normal and LFS fibroblasts. The duration of transient G1 arrest varied between strains, but there was no difference in the range between normal (2-12 h) and LFS (1-13 h) cells. However, the extent of permanent G1 arrest was greatly reduced in LFS fibroblasts (mean 33+/-8% of the cell population) compared with normals (mean 67+/-9%) and correlated with their increased radiation survival (r=0.97, P<0.001). This phenotype was observed in LFS fibroblasts both with (seven cases) and without (two cases) TP53 mutation. Parallel studies with fibroblasts derived from cancer-prone, p53-deficient mice revealed no radiation-induced G1 cell cycle arrest in p53 null (-/-) cells. The p53 +/- cells were comparable to the wt p53 cells in transient G1 arrest capacity, but showed a diminished permanent G1 arrest. These data clearly implicate p53 function in permanent G1 arrest. The reduced capacity for DNA damage-induced, permanent G1 arrest in LFS may contribute significantly to cancer predisposition in this familial syndrome.
在大约60%的李-佛美尼综合征(LFS)家族中,癌症易感性与TP53基因的种系突变有关。p53蛋白已被证明可介导DNA损伤后的G1期阻滞。我们研究了γ射线照射诱导的正常和LFS成纤维细胞中的短暂和永久性G1期阻滞。短暂G1期阻滞的持续时间因细胞株而异,但正常细胞(2 - 12小时)和LFS细胞(1 - 13小时)之间的范围没有差异。然而,与正常细胞(平均67±9%)相比,LFS成纤维细胞中永久性G1期阻滞的程度大大降低(平均占细胞群体的33±8%),并且与其辐射存活率的增加相关(r = 0.97,P < 0.001)。在有TP53突变(7例)和无TP53突变(2例)的LFS成纤维细胞中均观察到了这种表型。对来自易患癌症的p53缺陷小鼠的成纤维细胞进行的平行研究表明,p53基因敲除(-/-)细胞中没有辐射诱导的G1期细胞周期阻滞。p53杂合子(+/-)细胞在短暂G1期阻滞能力方面与野生型p53细胞相当,但永久性G1期阻滞有所减少。这些数据清楚地表明p53功能在永久性G1期阻滞中起作用。LFS中DNA损伤诱导的永久性G1期阻滞能力降低可能在很大程度上导致了这种家族性综合征中的癌症易感性。